XNASIVP
Market cap6mUSD
Dec 26, Last price
0.19USD
1D
6.04%
1Q
-61.17%
IPO
-95.09%
Name
Inspire Veterinary Partners Inc
Chart & Performance
P/E
—
P/S
0.37
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
17m
+69.56%
Net income
-15m
L+201.16%
CFO
-4m
L+43.73%
Profile
Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||
Revenues | 16,675 69.56% | 9,835 285.81% | 2,549 | |
Cost of revenue | 22,598 | 12,785 | 3,512 | |
Unusual Expense (Income) | ||||
NOPBT | (5,922) | (2,950) | (963) | |
NOPBT Margin | ||||
Operating Taxes | (30) | 74 | ||
Tax Rate | ||||
NOPAT | (5,922) | (2,920) | (1,038) | |
Net income | (14,793) 201.16% | (4,912) 269.02% | (1,331) 24,013.44% | |
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | 5,440 | 385 | ||
BB yield | -23,579.52% | |||
| Debt | ||||
Debt current | 3,425 | 5,540 | 1,498 | |
Long-term debt | 16,653 | 18,829 | 5,196 | |
Deferred revenue | ||||
Other long-term liabilities | ||||
Net debt | 19,899 | 23,925 | 4,635 | |
| Cash flow | ||||
Cash from operating activities | (3,821) | (2,658) | (1,010) | |
CAPEX | (384) | (177) | (1,311) | |
Cash from investing activities | (1,870) | (14,667) | (4,020) | |
Cash from financing activities | 5,625 | 15,711 | 7,067 | |
FCF | (4,764) | (8,955) | (3,073) | |
| Balance | ||||
Cash | 179 | 444 | 2,058 | |
Long term investments | ||||
Excess cash | 1,931 | |||
Stockholders' equity | (21,214) | (5,135) | (869) | |
Invested Capital | 38,848 | 23,611 | 6,693 | |
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | 67 | 112 | 112 | |
Price | 0.34 | |||
Market cap | 23 | |||
EV | 19,922 | |||
EBITDA | (4,508) | (2,341) | (879) | |
EV/EBITDA | ||||
Interest | 2,539 | 1,425 | 195 | |
Interest/NOPBT | ||||